Seer, Inc. (SEER): Cost of Revenue
$8.11M
Year ended 2025-12-31
$7.44M
Trailing 12 months to 2026-06-30
-1.2%
3-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $8.11M | +14.0% | 2026-03-02, From 2025-01-01 |
| 2024-12-31 | $7.12M | -12.8% | 2026-03-02, From 2024-01-01 |
| 2023-12-31 | $8.15M | -2.9% | 2025-03-03, From 2023-01-01 |
| 2022-12-31 | $8.40M | +162.1% | 2024-03-04, From 2022-01-01 |
| 2021-12-31 | $3.21M | n/a | 2023-03-06, From 2021-01-01 |
| 2020-12-31 | $0 | n/a | 2022-03-01, From 2020-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Seer, Inc. (SEER) | 2025-12-31 | $8.11M | +14.0% |
| Precipio, Inc. (PRPO) | 2025-12-31 | $13.34M | +21.6% |
| Bionano Genomics, Inc. (BNGO) | 2025-12-31 | $15.32M | -49.6% |
| Lifeloc Technologies, Inc (LCTC) | 2025-12-31 | $5.38M | +5.8% |
| Scientific Industries Inc (SCND) | 2025-12-31 | $3.75M | +34.4% |
| 908 Devices Inc. (MASS) | 2025-12-31 | $27.77M | +19.5% |
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | $36.64M | -6.9% |
| Quanterix Corp (QTRX) | 2025-12-31 | $73.94M | +36.1% |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | $114.22M | -2.1% |
Compare SEER, PRPO, BNGO, LCTC side by side · Screen every company in Laboratory Analytical Instruments ↗